The economic evaluation of pharmacotherapies for Parkinson's disease

被引：12

作者：

Coyle, D

Barbeau, A

Guttman, M

Baladi, JF

机构：

[1] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Clin Epidemiol Unit,Dept Med & Epidemiol, Ottawa, ON K1Y 4E9, Canada

[2] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Clin Epidemiol Unit,Dept Community Med, Ottawa, ON K1Y 4E9, Canada

[3] Novartis Pharma Canada Inc, Dorval, PQ, Canada

[4] Ctr Movement Disorders, Markham, ON, Canada

[5] Univ Toronto, Div Neurol, Dept Med & Psychiat, Toronto, ON, Canada

来源：

PARKINSONISM & RELATED DISORDERS | 2003年 / 9卷 / 05期

关键词：

health economics; cost-effectiveness; economic evaluation; Parkinson's disease;

D O I：

10.1016/S1353-8020(02)00116-5

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

As well as the significant clinical effects of Parkinson's disease (PD), the disease places a high economic burden on society. Given the scarcity of health care resources, it is becoming increasingly necessary to demonstrate that new therapies for PD provide value for money in comparison with other potential interventions. This paper outlines the basic techniques of cost-effectiveness analysis and its application to PD. These techniques are illustrated by a recent economic evaluation of entacapone for use in Canada. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：301 / 307

页数：7

共 50 条

[1] Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial
Sturkenboom, Ingrid H. W. M.
Hendriks, Jan C. M.
Graff, Maud J. L.
Adang, Eddy M. M.
Munneke, Marten
Nijhuis-van der Sanden, Maria W. G.
Bloem, Bastiaan R.
MOVEMENT DISORDERS, 2015, 30 (08) : 1059 - 1067
[2] Emerging Pharmacotherapies for Motor Symptoms in Parkinson's Disease
Majali, Mohammad Al
Sunnaa, Michael
Chand, Pratap
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2021, 34 (04) : 263 - 273
[3] Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
Dodel, Richard
Joensson, Bengt
Reese, Jens Peter
Winter, Yaroslav
Martinez-Martin, Pablo
Holloway, Robert
Sampaio, Cristina
Ruzicka, Evzen
Hawthorne, Graeme
Oertel, Wolfgang
Poewe, Werner
Stebbins, Glenn
Rascol, Oliver
Goetz, Christopher G.
Schrag, Anette
MOVEMENT DISORDERS, 2014, 29 (02) : 169 - 176
[4] Economic Evaluation of Interventions in Parkinson's Disease: A Systematic Literature Review
Afentou, Nafsika
Jarl, Johan
Gerdtham, Ulf-G
Saha, Sanjib
MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 282 - 290
[5] Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration
Perez-Lloret, Santiago
Peralta, Maria Cecilia
Barrantes, Francisco J.
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (18) : 2405 - 2415
[6] The economic impact of Parkinson's disease
Findley, Leslie J.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S8 - S12
[7] Longitudinal evaluation of economic and physical impact of Parkinson's disease
Schenkman, M
Zhu, CW
Cutson, TM
Whetten-Goldstein, K
PARKINSONISM & RELATED DISORDERS, 2001, 8 (01) : 41 - 50
[8] Economic Evaluation of Exercise-Based Fall Prevention Programs for People with Parkinson's Disease: A Systematic Review
Winser, Stanley John
Paul, Li Francis
Magnus, Leung Ka Long
Yan, Szeto
Shenug, Tsui Pui
Sing, Yuen Man
Cheing, Gladys
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1225 - 1237
[9] Economic evaluation of a falls prevention exercise program among people With Parkinson's disease
Farag, Inez
Sherrington, Catherine
Hayes, Alison
Canning, Colleen G.
Lord, Stephen R.
Close, Jacqueline C. T.
Fung, Victor S. C.
Howard, Kirsten
MOVEMENT DISORDERS, 2016, 31 (01) : 53 - 61
[10] An economic evaluation of deep brain stimulation for patients with Parkinson's disease
Dams, Judith
Dodel, Richard
MOVEMENT DISORDERS, 2016, 31 (08) : 1122 - 1124

← 1 2 3 4 5 →